| Institution: | 1. Medical Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland;2. Medical Oncology Hospital Vall d’Hebron and Hereditary Cancer Genetics Group, Vall d’Hebron Institut of Oncology, Barcelona, Spain;3. Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute/Harvard Medical School, Boston, USA;4. Champalimaud Foundation, Breast Unit and Faculdade de Medicina, Lisbon, Portugal;5. Department of Gynecologic Oncology, Istituto Europeo di Oncologia e IRCCS, Milan, Italy;6. Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy;7. Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS, Milan, Italy;8. Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy;9. Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA;10. Manchester Centre for Genomic Medicine, Division of Evolution Infection and Genomic Sciences, University of Manchester, MAHSC, Manchester, UK;11. Manchester Centre for Genomic Medicine, MAHSC, St Mary''s Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK;12. Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic;13. Breast Center, Department of Obstetrics & Gynecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany;14. Department of Diagnostic and Interventional Radiology, University Hospital Aachen, University Hospital Aachen (UKA), RWTH Aachen, Germany;15. KIU – Patient Organisation for Women with Gynaecological Cancer, Copenhagen, Denmark;16. Clinical Trials Project, ESGO ENGAGe, Prague, Czech Republic;17. Medical Genetics Institute, Shaare Zedek Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel;18. Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy;19. Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy;20. Department of Oncology, UCL Cancer Institute, University College London and UCL Hospitals, London, UK;21. GBG Forschungs GmbH, Neu-Isenburg, Germany;22. Department of Medical Oncology, Peter MacCallum Cancer Centre and The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia;23. Sharett Institute of Oncology Department, Hadassah University Hospital & Faculty of Medicine Hebrew University, Jerusalem, Israel |
